CIK: 0001832749 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $49,111 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LENZ | LENZ THERAPEUTICS INC | 1,017,751 | $29,382 | 59.8% | $20.79 | +46.6% | COM | 52635N103 |
| KRRO | KORRO BIO INC | 276,831 | $10,539 | 21.5% | $32.95 | +56.0% | COM | 500946108 |
| PRAX | PRAXIS PRECISION MEDICINES I | 65,933 | $5,074 | 10.3% | $18.01 | +301.8% | COM NEW | 74006W207 |
| ANRO | ALTO NEUROSCIENCE INC | 667,778 | $2,825 | 5.8% | $15.65 | -60.1% | COM SHS | 02157Q109 |
| CRBU | CARIBOU BIOSCIENCES INC | 474,067 | $754 | 1.5% | $24.45 | -91.8% | COM | 142038108 |
| — | TURNSTONE BIOLOGICS CORP | 549,980 | $273 | 0.6% | $3.94 | — | COM | 90042W100 |
| — | OMEGA THERAPEUTICS INC | 352,941 | $263 | 0.5% | $18.85 | — | COMMON STOCK | 68217N105 |